Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents-Reference-Cited by-同舟云学术

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents

Published:2018-04-16 Issue:1 Volume:34 Page:90-99
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Haase Volker H¹,Chertow Glenn M²,Block Geoffrey A³,Pergola Pablo E⁴,deGoma Emil M⁵,Khawaja Zeeshan⁵,Sharma Amit⁵,Maroni Bradley J⁵,McCullough Peter A⁶

Affiliation:

1. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

2. Stanford University School of Medicine, Palo Alto, CA, USA

3. Denver Nephrology, Denver, CO, USA

4. Renal Associates PA, San Antonio, TX, USA

5. Akebia Therapeutics Inc., Cambridge, MA, USA

6. Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, USA

Funder

Akebia Therapeutics, Inc

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/34/1/90/27376139/gfy055.pdf

Reference56 articles.

1. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes;Levey;Kidney Int,2007

2. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group;Kidney Int Suppl,2013

3. Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations;Schmidt;Osteopath Med Prim Care,2007

4. Anaemia in kidney disease: harnessing hypoxia responses for therapy;Koury;Nat Rev Nephrol,2015

5. Renal anemia of inflammation: the name is self-explanatory;Yilmaz;Blood Purif,2011

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease;Frontiers in Pharmacology;2023-12-06

2. An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients;Cureus;2023-07-17

3. Generic approach for the discovery of drug metabolites in horses based on data-dependent acquisition by liquid chromatography high-resolution mass spectrometry and its applications to pharmacokinetic study of daprodustat;Analytical and Bioanalytical Chemistry;2022-10-01

4. Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia;Journal of Pharmacology and Experimental Therapeutics;2022-08-04

5. Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control;Current Drug Metabolism;2022-08